Raymond James Financial Services Advisors’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Raymond James Financial Services Advisors’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-6,866	Closed	-$270K	–	3385
2023 Q2	$270K	Buy	+6,866	New	+$242K	﹤0.01%	2733

Raymond James Financial Services Advisors's ISEE Position: Q3 2023 in Review

Raymond James Financial Services Advisors sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 6,866 shares — an estimated $270K sold.

Raymond James Financial Services Advisors first reported a position in ISEE in Q2 2023 and held it in 1 quarter. The position peaked at $270K in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

Raymond James Financial Services Advisors reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Raymond James Financial Services Advisors sold 6,866 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $270K.
Raymond James Financial Services Advisors first reported a position in IVERIC bio, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
Raymond James Financial Services Advisors's IVERIC bio, Inc. Common Stock position peaked at $270K in Q2 2023.
0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on Raymond James Financial Services Advisors's 13F filing for Q3 2023, filed 24 Oct 2023.